KPC-Producing Klebsiella pneumoniae Isolates in Croatia: A Nationwide Survey

Marko Jelic1, Iva Butic1, Vanda Plecko2

  • 11 Department of Clinical Microbiology, University Hospital for Infectious Diseases , Zagreb, Croatia .

Microbial Drug Resistance (Larchmont, N.Y.)
|December 29, 2015
PubMed
Abstract

Insights

Multidrug-resistant Klebsiella pneumoniae producing carbapenemase (KPC) enzymes are spreading in Croatia. The ST258 strain is linked to early dissemination, primarily in the northwest region.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Emergence of multidrug-resistant Klebsiella pneumoniae strains producing K. pneumoniae carbapenemase (KPC) enzymes as significant pathogens in hospitalized patients.
  • KPC-producing K. pneumoniae represent a growing global health threat due to limited treatment options.

Purpose of the Study:

  • To describe the early dissemination of KPC-producing Klebsiella pneumoniae in Croatia.
  • To characterize the antimicrobial resistance mechanisms and genetic relatedness of these isolates.

Main Methods:

  • Analysis of 48 KPC-producing K. pneumoniae isolates collected between February 2011 and August 2013.
  • Antimicrobial susceptibility testing, pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and molecular identification of resistance genes (blaKPC, blaSHV, blaTEM).

Main Results:

  • KPC isolates were identified in 9 out of 40 participating centers in Croatia.
  • All isolates belonged to ST258 and were closely related by PFGE, indicating clonal spread.
  • The blaKPC-2 gene was detected in all isolates, located on plasmids of varying sizes. TEM-116 was the predominant TEM type.

Conclusions:

  • The early dissemination of KPC-producing K. pneumoniae in Croatia is driven by a successful ST258 clone.
  • The spread of this outbreak strain is currently geographically limited to the northwest region of Croatia.